LOGIN
ISAKOS2017: Liposomal bupivacaine no more effective than ropivacaine in LIA during TKA
July 2017
ISAKOS2017: Liposomal bupivacaine no more effective than ropivacaine in LIA during TKA
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Effectiveness of bupivacaine liposome injectable suspension for postoperative pain control in total knee arthroplasty: a prospective, randomized, double blind, controlled study
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
96 patients scheduled for total knee arthroplasty were randomized to local infiltration analgesia containing either liposomal bupivacaine or ropivacaine. Patients were assessed during their hospital stay for pain scores, narcotic consumption, and time to be able to walk 100 feet. Results demonstrated no significant differences between groups for any outcome.
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.